Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Oropharyngeal Squamous Cell Carcinoma”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Testing effectiveness (Phase 2)Looking for participantsNCT04852328
What this trial is testing

Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma
Washington University School of Medicine 30
Testing effectiveness (Phase 2)Looking for participantsNCT05784012
What this trial is testing

Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 34
Large-scale testing (Phase 3)Active Not RecruitingNCT00956007
What this trial is testing

RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 702
Not applicableUnknownNCT01946867
What this trial is testing

NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx

Who this might be right for
Head and Neck Cancer
Nanobiotix 75
Testing effectiveness (Phase 2)Study completedNCT03515538
What this trial is testing

Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

Who this might be right for
Oral Mucositis
EpicentRx, Inc. 53
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Large-scale testing (Phase 3)Study completedNCT00003888
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC 359
Testing effectiveness (Phase 2)Study completedNCT00352105
What this trial is testing

Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
David Adelstein 60
Testing effectiveness (Phase 2)Study completedNCT01695122
What this trial is testing

Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerOral Cavity CancerOropharyngeal Cancer
Instituto do Cancer do Estado de São Paulo 14
Early research (Phase 1)Study completedNCT00114153
What this trial is testing

Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Virginia 48
Testing effectiveness (Phase 2)Study completedNCT00851877
What this trial is testing

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Texas Southwestern Medical Center 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT05232851
What this trial is testing

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related CarcinomaLocally Advanced Oropharyngeal Carcinoma+2 more
Mayo Clinic 20
Large-scale testing (Phase 3)Ended earlyNCT00360971
What this trial is testing

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerMucositisPain+1 more
Radiation Therapy Oncology Group 21
Early research (Phase 1)Study completedNCT01935921
What this trial is testing

Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck Cancer

Who this might be right for
Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7+6 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00503997
What this trial is testing

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 42
Early research (Phase 1)Study completedNCT02113878
What this trial is testing

Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckHPV Positive Oropharyngeal Squamous Cell CarcinomaHypopharyngeal Cancer+3 more
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)UnknownNCT00251381
What this trial is testing

Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

Who this might be right for
Oropharyngeal Neoplasms
Trial Form Support S.L. 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+4 more
Inhibrx Biosciences, Inc 296
Large-scale testing (Phase 3)UnknownNCT00336947
What this trial is testing

S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Yokohama City University 500
Early research (Phase 1)WithdrawnNCT04892875
What this trial is testing

Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and NeckOral Cavity Squamous Cell Carcinoma+7 more
Jennifer Choe
Load More Results